|
A chronic disease associated with abnormally high levels of sugar in the blood. People with diabetes are at risk for developing high blood pressure.
|
Author:
Yngve, Agneta
Page:
971-972
]]>
Author:
Hughes, Roger
Page:
973
]]>
Author:
Cannon, Geoffrey
Page:
974-977
]]>
Author:
Lund, Vivien *; Stockley, Lynn; Levy, Louis
Page:
978-979
]]>
Author:
Gibson, Sigrid; on behalf of the Food Standards Agency
Page:
980-988
]]>
Author:
Oddy, W H 1,2; Miller, M 1; Payne, J M 1; Serna, P 1; Bower, C I 1,3,*
Page:
989-995
]]>
Author:
Senarath, Upul 1; Dibley, Michael J 2,*+; Agho, Kingsley E 3
Page:
996-1004
]]>
Author:
Giskes, Katrina 1,2,*; Kamphuis, Carlijn BM 2; van Lenthe, Frank J 2; Kremers, Stef 3; Droomers, Mariel 4; Brug, Johannes 2
Page:
1005-1017
]]>
Author:
Granado, F *; Blazquez, S and; Olmedilla, B +
Page:
1018-1023
]]>
Author:
Cowburn, Gill *; Boxer, Anna
Page:
1024-1031
]]>
Author:
Assey, Vincent D 1,2,*; Mgoba, Celestin 1; Mlingi, Nicholaus 1; Sanga, Alfred 1; Ndossi, Godwin D 1; Greiner, Ted 2,+; Peterson, Stefan 3,4
Page:
1032-1038
]]>
Author:
Madanat, Hala N 1,2,*; Brown, Ralph B 3; Hawks, Steven R 2
Page:
1039-1046
]]>
Author:
Mamabolo, R L 1,*; Kruger, H S 1; Lennox, A 2; Monyeki, M A 2; Pienaar, A E 2; Underhay, C 2; Czlapka-Matyasik, M 1
Page:
1047-1056
]]>
Author:
Smith, Albert F 1,*; Baxter, Suzanne Domel 2; Hardin, James W 3; Guinn, Caroline H 2; Royer, Julie A 2; Litaker, Mark S 4
Page:
1057-1066
]]>
Author:
Liu, Jian 1,*; Sempos, Christopher 2
Page:
1067-1076
]]>
Author:
Silvera, Stephanie AN 1,*; Jain, Meera 2; Howe, Geoffrey R 3; Miller, Anthony B 2; Rohan, Thomas E 4
Page:
1076-1081
]]>
Author:
Hendricks, M 1,*; Beardsley, J 2; Bourne, L 3; Mzamo, B 1,3; Golden, B 2
Page:
1082-1088
]]>
Author:
Su, Dada 1; Zhao, Yun 1; Binns, Colin 1,*; Scott, Jane 2; Oddy, Wendy 1
Page:
1089-1093
]]>
Author:
Hjartaker, Anette 1,2,*,+; Andersen, Lene Frost 3; Lund, Eiliv 2
Page:
1094-1103
]]>
Author:
Knudsen, Vibeke K 1,*; Hansen, Harald S 2; Ovesen, Lars 3; Mikkelsen, Tina B 1; Olsen, Sjurour F 1
Page:
1104-1110
]]>
|
|
Treatment Of Diabetes
By Hans
| Now a day's treatment has become a common disease among people. It is caused due to mismanagement of carbohydrate metabolism inside the body. is identified with the excessive production of urine, hunger, thirst and excessive loss of weight, blurred vision, and delay in healing of skin, repeated infection, and excessive fatigue. Now a day's treatment has become a common disease among people. It is caused due to mismanagement of carbohydrate metabolism inside the body. is identified with the excessive production of urine, hunger, thirst and excessive loss of weight, blurred vision, and delay in healing of skin, repeated infection, and excessive fatigue. has got a serous issue of human health. It denotes sugar in blood and urine very excessively. So, when it comes to treatment of the main concern should be given to control blood sugar, which is main cause of diabetes. Managing blood sugar is the stepping-stone of this treatment program. To remove the complications of one must take it seriously and adopt some good diet process or healthy exercise. Apart from doing so some take insulin and any other type of medication program to be cured to some extent. Frequent testing of blood sugar can denote you how much you have improved on your part to manage suitable measure of sugar in blood. It is very important to learn the right range of glucose in blood unless and until you cannot have the idea about the complication you are facing about this disease. It depends on age mainly such as in younger age assuming not much complication is there the suitable range of glucose is 80-120 mg/dL and in older age it is 100-140 mg/dL.
Diabetes program includes some specific self-treatments like having good and suitable diet, having proper exercise, maintaining healthy weight and medication. When it is about good and suitable diet it does not make any suggestion to take all dull food which are not of your interest rather it denotes to have more fruits, vegetables and grains that means you should be conscious in taking the foods of high nutrition and lower fat and calories. Avoid taking sweets and animal products with no limit. The main part of this treatment program is that you own self should be challenging in this task otherwise this program will be harder enough. Consult any dietitian about meal plan and try to maintain it at the fixed times every day with same amount according to your diet plan. On the part of having proper exercise you should be cautious about all aerobic exercises. In this treatment program you can make your choices among the daily exercises like doing morning or evening walk, jogging, hiking, biking, swimming and any other exercises of heart and lungs. Remember giving consistency to your exercise process is very important to get the best result through it. Try to maintain weight according to your activity level and age because overweight is dangerous factor which help to make your cells more resistant to insulin. Making suitable weight loss plan and going according to that can make its result more effectively. Sometimes medication takes a very important role in case where it is found that good dieting and exercise are not fulfilling it purpose. This type of program includes the insert of insulin as per requirement. As it can't be taken in form of pill some people have it injected by syringe or some have it with insulin pump. So now it is very clear that is always manageable if the sufferer give a serious daily attention to it. Although stands for life long suffering, yet it never means the end of your life. You just have to remember that the disease will be in your control only and only if you are self disciplined for your each and every step of treatment program. DISCLAIMER: This information is not presented by a medical practitioner and is for educational and informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read. Since natural and/or dietary supplements are not FDA approved they must be accompanied by a two-part disclaimer on the product label: that the statement has not been evaluated by FDA and that the product is not intended to "diagnose, treat, cure or prevent any disease."
Here are some more diabetes articles...
Diabetes Causes And Prevention
By Dr John
Diabetes is a disease that affects the body’s natural ability to change carbohydrates and sugars into energy. There is no known cause for the onset of Read more...
|
Acomplia Diet Pill: Go For The Perfect Body
By Michael Lucas
Growing weight problems are affecting so many of us, and it is reported that over half the UK population is either overweight or obese. In 2002, 70% of men and 63% of women were overweight. Moreover, Read more...
|
Efficacy of Adding Sitagliptin or Pioglitazone to T2DM Insufficiently Controlled With Metformin and Sulfonylurea
<b>Condition</b>: Type 2 Diabetes<br/><b>Interventions</b>: Drug: Sitagliptin; Drug: pioglitazone<br/><b>Sponsor</b>: Mackay Memorial Hospital<br/><b>Recruiting</b> - verified September 2010
Benefit/Risk Evaluation of Insuman Implantable Versus Insuplant Using Medtronic MiniMed Implantable Pump System in Patients With Type 1 Diabetes
<b>Condition</b>: Diabetes Mellitus, Type 1<br/><b>Interventions</b>: Drug: HUMAN INSULIN (BIOSYNTHETIC); Drug: Insuplant<br/><b>Sponsor</b>: Sanofi-Aventis<br/><b>Not yet recruiting</b> - verified September 2010
Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study
<b>Condition</b>: Diabetes Mellitus, Type 2<br/><b>Interventions</b>: Drug: Placebo; Drug: Linagliptin<br/><b>Sponsor</b>: Boehringer Ingelheim Pharmaceuticals<br/><b>Not yet recruiting</b> - verified September 2010
Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia
<b>Condition</b>: Type 1 Diabetes<br/><b>Intervention</b>: Drug: Formoterol<br/><b>Sponsors</b>: Yale University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Recruiting</b> - verified September 2010
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
<b>Condition</b>: Type 1 Diabetes<br/><b>Intervention</b>: Device: Diabetes Interactive Diary (DID)<br/><b>Sponsors</b>: Consorzio Mario Negri Sud; Sanofi-Aventis; LifeScan<br/><b>Recruiting</b> - verified September 2010
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 1 Diabetes Mellitus
<b>Condition</b>: Diabetes Mellitus, Type 1<br/><b>Intervention</b>: Drug: Insulin LISPRO<br/><b>Sponsor</b>: Halozyme Therapeutics<br/><b>Recruiting</b> - verified September 2010
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus
<b>Condition</b>: Diabetes Mellitus, Type II<br/><b>Intervention</b>: Drug: Insulin LISPRO<br/><b>Sponsor</b>: Halozyme Therapeutics<br/><b>Recruiting</b> - verified September 2010
Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes: An Extension Trial to NN1250-3579
<b>Condition</b>: Diabetes Mellitus, Type 2<br/><b>Interventions</b>: Drug: NN1250; Drug: insulin glargine<br/><b>Sponsor</b>: Novo Nordisk<br/><b>Not yet recruiting</b> - verified August 2010
Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With or Without Metformin and With/Without Pioglitazone in Type 2 Diabetes: An Extension Trial to NN1250-3582
<b>Condition</b>: Diabetes Mellitus, Type 2<br/><b>Interventions</b>: Drug: NN1250; Drug: insulin glargine; Drug: insulin aspart<br/><b>Sponsor</b>: Novo Nordisk<br/><b>Not yet recruiting</b> - verified August 2010
BI 10773 Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus
<b>Condition</b>: Diabetes Mellitus, Type 2<br/><b>Interventions</b>: Drug: BI 10773; Drug: BI 10773; Drug: BI 10773; Drug: BI 10773; Drug: Placebo<br/><b>Sponsor</b>: Boehringer Ingelheim Pharmaceuticals<br/><b>Not yet recruiting</b> - verified August 2010
Risk Factors for Low Lymphocyte Count in Patients With Type 2 Diabetes
<b>Condition</b>: Diabetes Mellitus, Type 2<br/><b>Intervention</b>: <br/><b>Sponsors</b>: Bristol-Myers Squibb; AstraZeneca<br/><b>Active, not recruiting</b> - verified August 2010
A Study of OPC-262 in Patients With Type 2 Diabetes
<b>Condition</b>: Diabetes, Type 2<br/><b>Intervention</b>: Drug: OPC-262<br/><b>Sponsor</b>: Otsuka Pharmaceutical Co., Ltd.<br/><b>Recruiting</b> - verified August 2010
Glycemic Holter Study (Continuous Glucose Monitoring) -
<b>Condition</b>: Type 2 Diabetes Mellitus<br/><b>Interventions</b>: Drug: Vildagliptin; Drug: Sitagliptin<br/><b>Sponsor</b>: Novartis<br/><b>Recruiting</b> - verified August 2010
Psychosocial Interventions in the Treatment of Youth With Type 1 Diabetes Mellitus
<b>Condition</b>: Diabetes Mellitus<br/><b>Intervention</b>: Behavioral: psychosocial intervention<br/><b>Sponsor</b>: Assaf-Harofeh Medical Center<br/><b>Recruiting</b> - verified August 2010
Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin XR Tablet (Manufactured in Mt Vernon, IN) Relative to 5 mg Saxagliptin Tablet and 500 mg Metformin XR Tablet (Manufactured in Evansville, IN)
<b>Condition</b>: Diabetes Mellitus<br/><b>Interventions</b>: Drug: saxagliptin; Drug: metformin XR; Drug: saxagliptin + metformin XR (FDC tablet)<br/><b>Sponsor</b>: Bristol-Myers Squibb<br/><b>Completed</b> - verified August 2010
Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin/1000 mg Metformin XR (Manufactured in Mt Vernon, IN) Relative to 5 mg of Onglyza and 2 × 500 mg Glucophage XR
<b>Condition</b>: Diabetes Mellitus<br/><b>Interventions</b>: Drug: saxagliptin; Drug: Glucophage XR; Drug: saxagliptin + metformin XR (FDC tablet)<br/><b>Sponsor</b>: Bristol-Myers Squibb<br/><b>Completed</b> - verified August 2010
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-4)
<b>Condition</b>: Diabetes Mellitus, Type 2<br/><b>Interventions</b>: Drug: Insulin Glargine; Drug: LY2189266<br/><b>Sponsor</b>: Eli Lilly and Company<br/><b>Not yet recruiting</b> - verified August 2010
Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes: An Extension Trial to NN1250-3585
<b>Condition</b>: Diabetes Mellitus, Type 1<br/><b>Interventions</b>: Drug: NN1250; Drug: insulin detemir (Levemir®); Drug: insulin aspart<br/><b>Sponsor</b>: Novo Nordisk<br/><b>Not yet recruiting</b> - verified August 2010
Exploratory Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus and Secondary Hypogonadism or Adult-Onset Idiopathic Hypogonadotropic Hypogonadism
<b>Conditions</b>: Type 2 Diabetes Mellitus; Secondary Hypogonadism<br/><b>Interventions</b>: Drug: Placebo; Drug: enclomiphene citrate<br/><b>Sponsor</b>: Repros Therapeutics Inc.<br/><b>Not yet recruiting</b> - verified August 2010
Subcutaneous Administration of Teplizumab in Adults With Type 1 Diabetes
<b>Condition</b>: Type 1 Diabetes Mellitus<br/><b>Intervention</b>: Drug: teplizumab or placebo<br/><b>Sponsors</b>: MacroGenics; Eli Lilly and Company<br/><b>Recruiting</b> - verified August 2010
Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Patients With Type 2 Diabetes Mellitus (0431-251)
<b>Condition</b>: Type 2 Diabetes Mellitus<br/><b>Interventions</b>: Drug: sitagliptin phosphate; Drug: Glimepiride<br/><b>Sponsor</b>: Merck<br/><b>Not yet recruiting</b> - verified August 2010
Four-Hour Evaluation of a Medical Food in Subjects With Type 2 Diabetes
<b>Condition</b>: Diabetes Mellitus, Type 2<br/><b>Interventions</b>: Other: Experimental nutritional formula #M979; Other: Standard food<br/><b>Sponsor</b>: Abbott Nutrition<br/><b>Completed</b> - verified July 2010
Modulation of Free Fatty Acids in Heart Failure Patients With Diabetes: "Effect on Left Ventricular Function"
<b>Conditions</b>: Heart Failure; Diabetes<br/><b>Interventions</b>: Other: Metabolic substrate modulation; Other: metabolic substrate modulation<br/><b>Sponsors</b>: University of Aarhus; Danish Heart Foundation<br/><b>Recruiting</b> - verified August 2010
Study of Two Oral Formulations of LX4211 in Patients With Type 2 Diabetes Mellitus
<b>Condition</b>: Type 2 Diabetes Mellitus<br/><b>Interventions</b>: Drug: 300 mg LX4211 (150 mg tablets); Drug: 300 mg LX4211 (50 mg tablets); Drug: 300 mg LX4211 (liquid)<br/><b>Sponsor</b>: Lexicon Pharmaceuticals<br/><b>Not yet recruiting</b> - verified August 2010
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
<b>Conditions</b>: Androgen Deficiency (AD); Erectile Dysfunction (ED); Development of Predictive Cardiovascular/Cerebrovascular AE<br/><b>Intervention</b>: <br/><b>Sponsors</b>: Mount Sinai School of Medicine; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Recruiting</b> - verified August 2010
A Multi-professional Team Intervention on Physical Activity Referrals in Primary Care Patients With Cardiovascular Risk Factors?the Dalby Lifestyle Intervention Cohort (DALICO) Study
<b>Condition</b>: Motivation for Physical Activity<br/><b>Interventions</b>: Behavioral: Multi-professional team intervention with PAR, lifestyle brochure; Behavioral: Ordinary recommendations on health behaviours, lifestyle brochure<br/><b>Sponsors</b>: Region Skane; Swedish Council for Working Life and Social Research<br/><b>Not yet recruiting</b> - verified August 2010
Exercise Program Combined or Not With Nutritional intErvention in Adults With tyPe 2 Diabetes
<b>Conditions</b>: Overweight; Obesity; Type 2 Diabetes<br/><b>Interventions</b>: Behavioral: Caloric restriction; Behavioral: Diet intervention and structured exercise training program<br/><b>Sponsor</b>: Institut de Recherches Cliniques de Montreal<br/><b>Not yet recruiting</b> - verified August 2010
A 12-week, Multicentric Study to Evaluate the Safety and Efficacy of Bisoprolol in Diabetic and Hypertensive Filipinos
<b>Condition</b>: Hypertension<br/><b>Intervention</b>: Drug: Bisoprolole<br/><b>Sponsor</b>: Merck KGaA<br/><b>Recruiting</b> - verified August 2010
Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial Hypertension
<b>Condition</b>: Arterial Hypertension<br/><b>Interventions</b>: Drug: Chlorthalidone 25 mg + amiloride hydrochloride 5 mg; Drug: Higroton® Laboratório Novartis<br/><b>Sponsor</b>: Eurofarma Laboratorios Ltda<br/><b>Not yet recruiting</b> - verified August 2010
n-3 Polyunsaturated Fatty Acids (PUFA) Supplementation in Young Women With Polycystic Ovary Syndrome (PCOS)
<b>Condition</b>: Polycystic Ovary Syndrome<br/><b>Intervention</b>: Dietary Supplement: LC n-3 PUFA (fish oil) Supplement<br/><b>Sponsors</b>: The Adelaide and Meath Hospital; University College Dublin<br/><b>Completed</b> - verified July 2008
|
|
|
Resources |
Medicinal Mushrooms Can Change Your Life
By ArticleTrader
Containing numerous compounds that work with the cells of the immune system, medicinal mushrooms have been studied for their amazing ability to activate the immune system’s cells. In order to get the Read more...
|
|
|
